In parallel, HCC patients with elevated stromal scores, immune scores, or estimate scores conferred a favorable prognosis in contrast with the CLEC1B low expression population (Fig. 4D-F). The gene discussed is CLEC1B; the disease is hepatocellular carcinoma.